166 related articles for article (PubMed ID: 31368817)
21. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
23. Propofol inhibits proliferation and epithelial-mesenchymal transition of MCF-7 cells by suppressing miR-21 expression.
Du Q; Zhang X; Zhang X; Wei M; Xu H; Wang S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1265-1271. PubMed ID: 30942630
[TBL] [Abstract][Full Text] [Related]
24. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
25. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
[TBL] [Abstract][Full Text] [Related]
26. Neferine inhibits MDA-MB-231 cells growth and metastasis by regulating miR-374a/FGFR-2.
Liu Z; Zhang S; Wang T; Shao H; Gao J; Wang Y; Ge Y
Chem Biol Interact; 2019 Aug; 309():108716. PubMed ID: 31207222
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
[TBL] [Abstract][Full Text] [Related]
28. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
29. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
[TBL] [Abstract][Full Text] [Related]
30. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
[TBL] [Abstract][Full Text] [Related]
31. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
32. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
33. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
34. Luteolin protects PC-12 cells from H
Zhang Z; Xu P; Yu H; Shi L
Biomed Pharmacother; 2019 Apr; 112():108698. PubMed ID: 30802826
[TBL] [Abstract][Full Text] [Related]
35. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression.
Zhang Y; Li J; Jia S; Wang Y; Kang Y; Zhang W
Biochem Cell Biol; 2019 Apr; 97(2):193-200. PubMed ID: 30352165
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
38. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
39. Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway.
Lin CH; Chang CY; Lee KR; Lin HJ; Chen TH; Wan L
BMC Cancer; 2015 Dec; 15():958. PubMed ID: 26675309
[TBL] [Abstract][Full Text] [Related]
40. Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells.
Choi AY; Choi JH; Yoon H; Hwang KY; Noh MH; Choe W; Yoon KS; Ha J; Yeo EJ; Kang I
Eur J Pharmacol; 2011 Oct; 668(1-2):115-26. PubMed ID: 21762691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
